A detailed history of Bamco Inc transactions in Natera, Inc. stock. As of the latest transaction made, Bamco Inc holds 35,000 shares of NTRA stock, worth $5.43 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
35,000
Previous 41,000 14.63%
Holding current value
$5.43 Million
Previous $4.44 Million 0.2%
% of portfolio
0.01%
Previous 0.01%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$97.75 - $129.67 $586,500 - $778,019
-6,000 Reduced 14.63%
35,000 $4.45 Million
Q1 2024

May 15, 2024

BUY
$59.21 - $92.9 $1.03 Million - $1.62 Million
17,400 Added 73.73%
41,000 $3.75 Million
Q4 2023

Feb 14, 2024

BUY
$37.55 - $62.64 $886,179 - $1.48 Million
23,600 New
23,600 $1.48 Million
Q1 2022

May 13, 2022

SELL
$30.32 - $91.33 $21 Million - $63.3 Million
-693,462 Closed
0 $0
Q4 2021

Feb 14, 2022

BUY
$86.26 - $119.0 $3.3 Million - $4.56 Million
38,285 Added 5.84%
693,462 $64.8 Million
Q3 2021

Nov 12, 2021

BUY
$100.17 - $126.36 $65.6 Million - $82.8 Million
655,177 New
655,177 $73 Million

Others Institutions Holding NTRA

About Natera, Inc.


  • Ticker NTRA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 96,957,400
  • Market Cap $15B
  • Description
  • Natera, Inc., a diagnostics company, develops and commercializes molecular testing services worldwide. It offers Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother, as well as twin pregnancies for zygosity; Vistara, a single-gene mutations screening test to identify sing...
More about NTRA
Track This Portfolio

Track Bamco Inc Portfolio

Follow Bamco Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bamco Inc , based on Form 13F filings with the SEC.

News

Stay updated on Bamco Inc with notifications on news.